Literature DB >> 22754860

Osteosarcoma as a second malignant disease in a case of bilateral retinoblastoma.

G Agarwal, H S Kochar, P K Julka, S Bahadur.   

Abstract

Patients with hereditary retinoblastoma, whether treated by radiation or not, are at an increased risk of subsequently developing sarcomas as a second malignancy. As the understanding of the underlying genetics of osteosarcoma and retinoblastoma has improved, a clear association between the two entities has been noted. We present a case of a young patient with previous history of bilateral retinoblastoma who was treated by surgery and chemoradiation for his primary disease and subsequent recurrences. Thirteen years after his initial diagnosis, he developed osteosarcoma of the mandible as the second primary lesion and was treated with surgery and chemotherapy. The intent of the case report is to bring forth the current thinking of genetic association between retinoblastoma and osteosarcoma and to discuss aggressive treatment protocol for the latter, in the form of surgery and chemotherapy.

Entities:  

Keywords:  Osteosarcoma; Retinoblastoma

Year:  2011        PMID: 22754860      PMCID: PMC3146676          DOI: 10.1007/s12070-011-0254-2

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  8 in total

1.  Sarcoma arising in irradiated bone; report of 11 cases.

Authors:  W G CAHAN; H Q WOODARD
Journal:  Cancer       Date:  1948-05       Impact factor: 6.860

2.  Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases.

Authors:  D G Sheppard; H I Libshitz
Journal:  Clin Radiol       Date:  2001-01       Impact factor: 2.350

3.  Alterations of the p53, Rb and MDM2 genes in osteosarcoma.

Authors:  C W Miller; A Aslo; A Won; M Tan; B Lampkin; H P Koeffler
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases.

Authors:  M D Tabone; P Terrier; H Pacquement; M Brunat-Mentigny; C Schmitt; A Babin-Boilletot; H H Mahmoud; C Kalifa
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

5.  Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group.

Authors:  S S Bielack; B Kempf-Bielack; U Heise; D Schwenzer; K Winkler
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

Review 6.  Radiation-induced osteosarcomas in the pediatric population.

Authors:  Matthew Koshy; Arnold C Paulino; Wei Y Mai; Bin S Teh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-28       Impact factor: 7.038

Review 7.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Sarcomas of bone complicating osteitis deformans (Paget's disease): fifty years' experience.

Authors:  M R Wick; G P Siegal; K K Unni; R A McLeod; H G Greditzer
Journal:  Am J Surg Pathol       Date:  1981-01       Impact factor: 6.394

  8 in total
  2 in total

1.  A review of the mechanism of action and clinical applications of sorafenib in advanced osteosarcoma.

Authors:  James Coventon
Journal:  J Bone Oncol       Date:  2017-08-04       Impact factor: 4.072

Review 2.  Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review.

Authors:  Kelly M Makielski; Lauren J Mills; Aaron L Sarver; Michael S Henson; Logan G Spector; Shruthi Naik; Jaime F Modiano
Journal:  Vet Sci       Date:  2019-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.